Israel’s Microtech (part of Medinol – see here previously) has begun human clinical trials of their microsensor platform, to measure atrial pressures, vital for the treatment of heart failure. The tiny device is implanted and uses ultrasound to communicate, reducing … Continue reading →

The US FDA has approved the EluNIR medicated stent developed by Israel’s Medinol for the treatment of blocked or narrow coronary arteries. The stent system has a novel metallic spring tip and the narrowest strut width of any stent on … Continue reading →